FDA Inspection
VitalantVitalant – FDA Inspection, Apr 17, 2013
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on April 17, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- April 17, 2013
- Product Type
- Biologics
View Company Profile
ID · 6bc4d130-cbae-4b39-9675-c883d9cba194
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 828029
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 13, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 24, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 3, 2017 | Not classified | Seattle District Office | |
| May 11, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 7, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1256346 - 2024-11-13
- FDA Inspection 1098186 - 2019-06-24
- FDA Inspection 1009750 - 2017-05-03
- FDA Inspection 925827 - 2015-05-11
- FDA Inspection 744380 - 2011-09-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.